The WinSanTor team consists of experienced business and regulatory executives and opinion leaders with unique insights into the development of neuropathy treatments and scientific experts with strong track records in the biopharmaceutical industry. WinSanTor also retains a science and technology advisory team composed of renowned experts, industry veterans, and opinion leaders with neuropathy and biopharmaceutical experience. WinSanTor is rigorously pursuing a science-driven approach to translational medicine and clinical development.
Leadership
Stanley is a seasoned entrepreneur and the founder of companies in diverse industries…
Paul is the Chairman of the Department of Pharmacology & Therapeutics…
Nigel is the Professor of Pathology at the University of California San Diego (UCSD)…
Lakshmi is the Director at the Center for Molecular Design and Preformulations…
Andrew is the controller here at WinSanTor. He was previously the Vice…
Anne was recruited to work with our investors and donors. She has a…
Angela has spent 20 years in pharmaceutical/drug development operations…
Katie Frizzi Lynch graduated from Georgia State University with a B.S. in…
